In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Heron Therapeutics Inc.

www.herontx.com

Latest From Heron Therapeutics Inc.

Keeping Track: US FDA Approves Sanofi’s Dengvaxia, But Heron’s HTX-011 And Nabriva’s Contepo Fall Short

The latest drug development news and highlights from our US FDA Performance Tracker.
Approvals Drug Review

FDA Finalizes Comparative Safety, Efficacy Requirement For New Opioids

New opioids will need to provide a “significant advantage” over approved products under new requirements that treat opioids “differently” from other drug classes, outgoing Commissioner Gottlieb says.
Neurology Drug Review

Keeping Track Of Oncology: US FDA Approves Herceptin Hylecta, Reviews Darolutamide And Pexidartinib

Oncology news and highlights from our US FDA Performance Tracker.
Cancer Approvals

Hazards Ahead For New Drugs At US FDA Amid Safety Concerns, Shutdown Disruption

The pipeline for new drug candidates remains healthy as 2019 begins, with almost 40 novel agents already under FDA review. But the chances of another record-breaking year are threatened by a confluence of safety issues that are putting risk management back in the spotlight – and by the widening ripple effects of the recent US government shutdown.

Drug Review Approvals
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
    • Drug Delivery
      • Controlled Release
  • Therapeutic Areas
  • Gastrointestinal
  • Neurology, Nervous System
  • Alias(es)
  • AP Pharma Inc.
  • Advanced Polymer Systems Inc.
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Heron Therapeutics Inc.
  • Senior Management
  • Barry D Quart, PharmD, CEO
    Robert E Hoffman, SVP, Fin. & CFO
    Robert Rosen, Pres.
    David L Szekeres, SVP, Bus. Dev., General Counsel
    Kimberly J Manhard, EVP, Drug Dev.
    Paul Blake, FRCP, CMO
    Thomas B Ottoboni, SVP, Pharma and PC R&D
    Anita Gupta, PharmD, SVP, Medical Strategy &Govt Affairs
    John C Arthur, VP, Mfg & Supply
  • Contact Info
  • Heron Therapeutics Inc.
    Phone: (650) 366-2626
    4242 Campus Point Court
    Suite 200
    San Diego, CA 92121
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register